Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug (Published 2024)

The New York Times·Jun 10

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

An advisory panel of experts has endorsed fda approval of a new alzheimer's drug. However, the headlines also mention the panel's involvement with other pharmaceuticals, including a moderna flu vaccine and a pfizer vaccine booster, with varying outcomes. It is unclear how these other endorsements or rejections may relate to the alzheimer's drug approval.

Full coverage

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

STAT·Jun 18

FDA’s ODAC Recognizes MRD as an Accepted End Point for Accelerated Approval in Multiple Myeloma

OncLive·Apr 12

FDA advisory panel rejects widespread Pfizer vaccine booster shots

PBS·Sep 17

FDA Advisory Panel Votes Against Endorsing Covid-19 Booster Shots Widely

WSJ·Sep 17

View original report at The New York Times ↗

Fetching the latest headlines…

Advisory Panel of Experts Endorses F.D.A. Approval of New Alzheimer’s Drug (Published 2024)

Full coverage

FDA experts endorse Moderna's mRNA seasonal flu shot

Moderna flu vaccine wins unanimous support from FDA panel

Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs

FDA Advisory Committee Endorses Safety of Exa-Cel in SCD

FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy

FDA’s ODAC Recognizes MRD as an Accepted End Point for Accelerated Approval in Multiple Myeloma

FDA advisory panel rejects widespread Pfizer vaccine booster shots

FDA Advisory Panel Votes Against Endorsing Covid-19 Booster Shots Widely